Akerke Chayakova | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Akerke Chayakova
Astana Medical University, Kazakhstan

Akerke Chayakova
Affiliation Astana Medical University
Country Kazakhstan
Scopus ID 57226888892
Documents 4
Citations 6
h-index 2
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-8398-3684

Akerke Chayakova is affiliated with Astana Medical University and has contributed to research in medicine, emergency healthcare systems, public health analytics, and the application of digital technologies in healthcare. Her scholarly activities focus on emergency medical services, epidemiological assessment, geospatial health analysis, and healthcare decision-making processes. Through peer-reviewed publications and interdisciplinary investigations, her work contributes to evidence-based healthcare planning and the understanding of population-level health dynamics.[1]

Abstract

This article summarizes the research profile and academic contributions of Akerke Chayakova. Her research addresses emergency medical service performance, urban health environments, healthcare analytics, pandemic response assessment, and artificial intelligence applications in medicine. Through quantitative investigations and population-based studies, her work supports improvements in healthcare management, emergency response planning, and clinical decision support systems.[2]

Keywords

Emergency Medical Services, Public Health, Healthcare Analytics, Artificial Intelligence, Epidemiology, Geospatial Analysis, Medical Informatics, Health Systems Research.

Introduction

Contemporary healthcare research increasingly relies on data-driven approaches to understand disease patterns, optimize emergency response systems, and improve patient outcomes. Akerke Chayakova’s research aligns with these priorities by examining emergency healthcare utilization, environmental influences on health events, and the integration of innovative technologies into clinical practice.[3]

Research Profile

Her scholarly profile includes publications addressing cardiovascular emergencies, traumatic injury response systems, COVID-19 healthcare management, and the role of artificial intelligence in disease screening. These studies employ retrospective analyses, geospatial methodologies, and health data evaluation techniques to investigate factors affecting healthcare delivery and patient management.[4]

Research Contributions

  • Investigation of emergency medical service utilization and transport decision-making in ischemic heart disease.
  • Analysis of urban environmental factors influencing traumatic injury response patterns.
  • Assessment of emergency medical services during the COVID-19 pandemic.
  • Evaluation of artificial intelligence applications in periodontal disease diagnosis and screening.

Publications

  • Beyond Clinical Acuity: Cardiac Comorbidity and Complication Profiles and the Prehospital Hospitalization/Transport Decision in Ischemic Heart Disease (Healthcare, 2026).
  • Urban Environmental Determinants and Spatiotemporal Patterns of Emergency Medical Service Response to Traumatic Injuries (IJERPH, 2026).
  • Modern Approaches to the Integration of Artificial Intelligence into the Diagnosis and Screening of Periodontal Diseases (2026).
  • Geospatial and Temporal Analysis of Emergency Medical Services during the COVID-19 Pandemic (2025).

Research Impact

According to the available Scopus author profile, Akerke Chayakova has accumulated scholarly visibility through indexed publications, citations, and an emerging citation record. Her research contributes to public health evidence, healthcare planning, emergency response optimization, and digital health innovation. The integration of epidemiological analysis with practical healthcare challenges demonstrates the translational relevance of her work.[1]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful contributions to their disciplines. Akerke Chayakova’s investigations into emergency medical systems, healthcare analytics, public health challenges, and artificial intelligence applications in medicine align with the objectives of innovation-focused academic recognition programs. Her interdisciplinary approach highlights the practical value of research in improving healthcare outcomes and system efficiency.[5]

Conclusion

Akerke Chayakova has established a developing research profile centered on medicine and health sciences. Her work contributes to the understanding of emergency healthcare systems, public health management, and emerging digital healthcare solutions. The combination of methodological analysis and healthcare application supports her recognition within contemporary medical research environments.

References

  1. Elsevier. (n.d.). Scopus author details: Akerke Chayakova, Author ID 57226888892. Scopus.
    https://www.scopus.com/pages/authors/57226888892
  2. Healthcare. (2026). Beyond Clinical Acuity: Cardiac Comorbidity and Complication Profiles.
    https://doi.org/10.3390/healthcare14152308
  3. International Journal of Environmental Research and Public Health. (2026). Urban Environmental Determinants and Spatiotemporal Patterns.
    https://doi.org/10.3390/ijerph23040434
  4. Journal of Health Development. (2026). Artificial Intelligence in Diagnosis and Screening of Periodontal Diseases.
    https://doi.org/10.32921/2663-1776-2026-61-1-jhd059
  5. Portuguese Journal of Public Health. (2025). Geospatial and Temporal Analysis of Emergency Medical Services during the COVID-19 Pandemic.
    https://doi.org/10.1159/000549009

Charles Timumpi Nignang | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Charles Timumpi Nignang
Affiliation University for Development Studies
Country Ghana
Documents 3
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0009-0005-8929-5267

Charles Timumpi Nignang

University for Development Studies, Ghana

Charles Timumpi Nignang is a researcher affiliated with the University for Development Studies, Ghana, whose scholarly work focuses on medicine and public health with particular emphasis on adolescent health, reproductive health, qualitative health research, and community-centered healthcare interventions. His recent peer-reviewed publications contribute evidence supporting equitable access to healthcare services through culturally appropriate and participatory research approaches. His research demonstrates the importance of engaging young people, healthcare professionals, and families in designing sustainable health interventions within resource-limited settings. These contributions provide valuable insights for healthcare policy, implementation science, and preventive medicine while strengthening evidence-based public health practice.[1]

Abstract

This article summarizes the academic profile and research contributions of Charles Timumpi Nignang. His published studies emphasize youth sexual and reproductive health, cervical cancer prevention, peer-led health education, and qualitative healthcare research in Northern Ghana. Through collaborative and evidence-based investigations, his work contributes practical knowledge for strengthening public health services, promoting inclusive healthcare delivery, and informing future intervention strategies within diverse community settings.[2]

Keywords

Medicine, Public Health, Adolescent Health, Reproductive Health, Qualitative Research, Cervical Cancer Prevention, Peer-Led Intervention, Community Health, Ghana.

Introduction

Healthcare research addressing youth engagement and preventive medicine has become increasingly important in improving long-term health outcomes. Charles Timumpi Nignang’s research aligns with these priorities by exploring barriers to healthcare access, promoting participatory intervention design, and evaluating culturally appropriate approaches that support equitable healthcare delivery.[3]

Research Profile

His current scholarly record includes three peer-reviewed journal publications in internationally recognized medical journals. The research primarily applies qualitative methodologies to understand healthcare experiences among adolescents, healthcare workers, and families. These investigations support evidence-informed decision-making while contributing to implementation research in reproductive and preventive healthcare.[1]

Research Contributions

  • Investigated youth access to sexual and reproductive health services.
  • Developed formative evidence for peer-led contraceptive counselling programs.
  • Examined family-centered approaches supporting cervical cancer prevention.
  • Applied qualitative methods to strengthen community-based healthcare interventions.

Publications

  • A Qualitative Study on Youth and Healthcare Provider Perspectives on Youth Access to Sexual and Reproductive Health Services in Northern Ghana.
  • Co-Designing a Peer-Led Contraceptive Counselling Program in Northern Ghana.
  • My Wife’s Healthcare Is My Healthcare.

Research Impact

The published studies provide evidence supporting adolescent reproductive health services, peer-supported counselling models, and family engagement in preventive healthcare. These contributions are relevant to public health practitioners, researchers, policymakers, and healthcare organizations seeking practical approaches for improving health outcomes within community settings.[4]

Award Suitability

Based on the available scholarly record, Charles Timumpi Nignang demonstrates active research engagement in medicine and health sciences through peer-reviewed publications addressing significant public health challenges. His research aligns with the objectives of the Innovative Research Award by emphasizing scientific evidence, healthcare innovation, community participation, and knowledge translation.[5]

Conclusion

Charles Timumpi Nignang’s publications contribute to contemporary discussions surrounding adolescent health, preventive medicine, and community-centered healthcare delivery. His qualitative research offers practical evidence that may support future public health interventions and collaborative healthcare initiatives in Ghana and similar settings.

References

  1. Elsevier. (n.d.).  Author details: Charles Timumpi Nignang
  2. International Journal of Environmental Research and Public Health. (2026). A Qualitative Study on Youth and Healthcare Provider Perspectives on Youth Access to Sexual and Reproductive Health Services in Northern Ghana.
    https://doi.org/10.3390/ijerph23070915
  3. Journal of Adolescent Health. (2026). Co-Designing a Peer-Led Contraceptive Counselling Program in Northern Ghana.
    https://doi.org/10.1016/j.jadohealth.2025.12.221
  4. Cancer Control. (2026). My Wife’s Healthcare Is My Healthcare.
    https://doi.org/10.1177/10732748261448259
  5. International Forensic Scientist Awards. (2026). Innovative Research Award.
    forensicscientist.org

Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Dr. Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Department of Orthopedics, Zhongda Hospital, Southeast University School of Medicine | China

Dr. Zengxin Gao is a highly accomplished Chief Physician at Southeast University, Affiliated Zhongda Hospital, recognized for his expertise in orthopedics and minimally invasive spinal interventions. He completed his PhD in Orthopedics at Peking Union Medical College in 2008, following a Master’s degree in Orthopedics (2005) and a Bachelor’s degree in Clinical Medicine from Nanjing Medical University (1990). Dr. Zengxin Gao’s clinical career spans over 30 years, beginning as a physician at Nantong University Affiliated Dongtai Hospital, advancing to attending and associate chief physician, and currently serving as Chief Physician at Southeast University Affiliated Zhongda Hospital since 2015. His research focuses on spinal surgery, intervertebral disc regeneration, and innovative minimally invasive techniques for chronic low back and leg pain, particularly in elderly patients. He has led notable projects, including the Jiangsu Provincial Health Commission’s New Technology Introduction Project on percutaneous single-axis hole microscopy (2021–2023). Dr. Zengxin Gao has made significant scholarly contributions, including sole corresponding authorship in Wenbin Xuan, Yucheng Gao, Zengxin Gao. Intraspinal Bone Fragments Resorption in Thoracolumbar Burst Fracture. JAMA Neurol. 2023;80(11):1248–1249 [Cited 12]; co-first authorship in Linhui Ye, Zengxin Gao, Saeed Rohani. Intervertebral disk regeneration in a rat model by allopurinol-loaded Chitosan/alginate hydrogel. Biomol Biomed. 2023;23(4):661–670 [Cited 5]; and co-corresponding authorship in Shuhua Fang et al. Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskelet Disord. 2024;25:5 [Cited 3]. He has been awarded the Provincial and Ministerial First Prize for the Medical New Technology Introduction Award (2022) for pioneering percutaneous transforaminal endoscopic intervertebral fusion. Dr. Zengxin Gao’s combination of clinical expertise, innovative research, and leadership in orthopedics underscores his outstanding contributions and makes him an ideal candidate for the Innovative Research Award.

Profile: Scopus

Featured Publications

• Xuan, W., Gao, Y., & Gao, Z. (2023). Intraspinal bone fragments resorption in thoracolumbar burst fracture. JAMA Neurology, 80(11), 1248–1249.
https://doi.org/10.1001/jamaneurol.2023.2901

• Ye, L., Gao, Z., & Rohani, S. (2023). Intervertebral disk regeneration in a rat model by allopurinol-loaded chitosan/alginate hydrogel. Biomolecules and Biomedicine, 23(4), 661–670.
https://doi.org/10.17305/bjbms.2023.8535

• Fang, S., Cao, D., Wu, Z., Chen, J., Huang, Y., Shen, Y., & Gao, Z. (2024). Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskeletal Disorders, 25(1), 5.
https://doi.org/10.1186/s12891-023-07172-0

• Gao, Z., Lin, Y., Wu, Z., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2020). LncRNA SNHG6 can regulate the proliferation and apoptosis of rat degenerate nucleus pulposus cells via regulating the expression of miR-101-3p. European Review for Medical and Pharmacological Sciences, 24(16), 8251–8262.
https://doi.org/10.26355/eurrev_202008_22592

• Gao, Z., Lin, Y., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2019). Sinomenine ameliorates intervertebral disc degeneration via inhibition of apoptosis and autophagy in vitro and in vivo. American Journal of Translational Research, 11(9), 5956–5966.
https://www.ajtr.org/files/ajtr0094769.pdf

Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Mr. Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Beijing Stomatological Hospital Affiliated to Capital Medical University | China

Hanchen Zhou, a graduate student at Beijing Stomatological Hospital, Capital Medical University, is an emerging researcher specializing in Oral and Maxillofacial-Head and Neck Oncology, with a primary focus on oral squamous cell carcinoma. He has already distinguished himself by publishing four SCI-indexed research papers that contribute valuable insights into the molecular mechanisms, clinical behavior, and potential treatment strategies for this aggressive malignancy. These publications, cited internationally, reflect his growing influence in oncology research and his ability to translate clinical challenges into innovative scientific solutions. Zhou is actively engaged in funded research projects, including the Innovation Foundation and the Clinical Research Incubation Project of Beijing Stomatological Hospital, demonstrating his capacity to design and execute impactful investigations. A member of the Chinese Stomatological Association, he actively participates in academic collaboration and professional development, strengthening his role within the wider scientific community. Despite being in the early stages of his career, Zhou has already showcased a strong commitment to advancing cancer research, particularly in bridging experimental findings with clinical applications. His work not only enhances the understanding of oral squamous cell carcinoma but also paves the way for improved diagnostic and therapeutic approaches. By integrating scientific rigor with a clear vision for innovation, he exemplifies the qualities of a promising researcher poised for long-term impact.

Profile: Scopus | ResearchGate

Featured Publications

  • Yu, H., Li, B., Huang, Y., & Zhang, X. (2025). Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: A retrospective cohort analysis. Frontiers in Oncology, 15, Article 1667226. https://doi.org/10.3389/fonc.2025.1667226

  • Zhou, H., Luo, C., Xu, Q., & Wang, C. (2025). Machine learning approach to predict surgical site infection in head and neck squamous cell carcinoma patients after free flap reconstruction. Journal of Cranio-Maxillofacial Surgery. Advance online publication. https://doi.org/10.1016/j.jcms.2025.09.010

  • Cheng, A., Wei, K., Xu, Q., & Wang, C. (2025). The comparison of the prognostic value of different inflammation-related indicators in patients with oral squamous cell carcinoma. Frontiers in Genetics, 16, Article 1652603. https://doi.org/10.3389/fgene.2025.1652603

  • Li, B., Zhao, Z., Huang, Y., & Zhou, H. (2025). The application of adjuvant radiotherapy in pN1 OSCC patients without adverse pathologic features. Oral Diseases, 31(1), e15336. https://doi.org/10.1111/odi.15336

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Liliang Li | Medicine and Health Sciences | Excellence in Innovation Award

Published on by Forensic Scientist Awards

Prof. Liliang Li | Medicine and Health Sciences | Excellence in Innovation Award

Fudan University | China

Prof. Liliang Li is a leading Associate Professor at Fudan University Shanghai Medical College, recognized for her pioneering research in forensic medicine, cardiovascular biology, and translational pharmacology. She has made significant contributions to understanding the molecular mechanisms underlying antipsychotic-induced cardiotoxicity, diabetic heart injuries, and sudden unexplained death in psychiatric patients. Combining innovative molecular approaches with clinical applications, Dr. Li’s research has consistently bridged basic science and translational medicine, influencing both diagnostic strategies and therapeutic development.

Professional Profile

Scopus

ORCID

Education

Prof. Liliang Li received her medical degree in Forensic Medicine followed by a doctoral degree in Forensic Science from Fudan University Shanghai Medical College. She enhanced her academic foundation and international exposure through postdoctoral training and a visiting scholar program at the University of Maryland School of Medicine, enabling her to integrate global perspectives into her research.

Experience

Prof. Liliang Li has built an impressive academic and research career, progressing from postdoctoral fellow to Associate Research Fellow, and ultimately assuming her current role as Associate Professor. She has played key roles in mentoring young researchers, organizing graduate research conferences, and serving as a talent specialist. She actively participates in professional committees, including leadership positions within the Shanghai Society of Forensic Medicine, the Shanghai Association of Forensic Expertise, and cardiovascular research societies, demonstrating both scientific excellence and professional commitment.

Research Interests

Her research focuses on the mechanisms of antipsychotic-induced cardiotoxicity, cannabinoid receptor-mediated myocardial signaling, and cell death pathways including necroptosis and pyroptosis. Prof. Liliang Li is particularly interested in the identification of biomarkers for sudden cardiac death and diabetic cardiac injuries. Her work integrates multi-omics approaches, including proteomics, transcriptomics, and molecular biology, to unravel complex cardiovascular and forensic phenomena, with an emphasis on developing translational strategies for clinical and forensic applications.

Awards

Prof. Liliang Li’s innovative work has been widely recognized with numerous prestigious awards, including Young Investigator accolades, national and regional medical science awards, and multiple best paper honors at leading cardiology conferences. She has been nominated for international awards in toxicology, chaired sessions at major scientific meetings, and serves as a reviewer for high-impact journals in cardiovascular medicine, translational research, and molecular biology. These accolades reflect her influence on both national and international scientific communities.

Publications

  • Title: Coenzyme Q deficiency may predispose to sudden unexplained death via an increased risk of cardiac arrhythmia
    Journal: International Journal of Legal Medicine
    Published on: 2024

  • Title: RNF149 Destabilizes IFNGR1 in Macrophages to Favor Postinfarction Cardiac Repair
    Journal: Circulation Research
    Published on: 2024

  • Title: Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
    Journal: Clinical Science
    Published on: 2024

  • Title: Post-mortem genetic analysis of sudden unexplained death in a young cohort: a whole-exome sequencing study
    Journal: International Journal of Legal Medicine
    Published on: 2023

  • Title: Nasal mucosa is much more susceptible than oral mucosa to infection of SARS‐CoV‐2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used
    Journal: Journal of Medical Virology
    Published on: 2023

  • Title: Sudden unexplained death in schizophrenia patients: An autopsy-based comparative study from China
    Journal: Asian Journal of Psychiatry
    Published on: 2023

  • Title: Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries
    Journal: Circulation
    Published on: 2023

Conclusion

Prof. Liliang Li is an exceptional scientist whose work exemplifies innovation, rigor, and translational impact. Her integration of forensic science, molecular cardiology, and translational medicine has led to new insights into drug-induced cardiotoxicity and sudden cardiac death. With a remarkable combination of research excellence, leadership, and mentorship, Dr. Li continues to shape the future of cardiovascular and forensic research, making her a highly deserving candidate for the Excellence in Innovation Award.

Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Published on by Forensic Scientist Awards

Dr. Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Endocrine and Metabolism Research Center | Iran

Dr. Fatemeh Shirani is a distinguished scholar in the field of Nutritional Sciences, renowned for her groundbreaking contributions to clinical nutrition, dietary epidemiology, and metabolic health. She has consistently advanced the understanding of how diet and nutrition influence chronic disease prevention and treatment, with a strong emphasis on obesity, diabetes, and cardiovascular disease. Through her innovative research and global collaborations, she has established herself as a thought leader whose work bridges scientific evidence with practical dietary strategies for public health. Currently serving at the Endocrine and Metabolism Research Center of Isfahan University of Medical Sciences, she has become a role model for women in science through her dedication, mentorship, and international engagement.

Professional Profile

Google Scholar

ORCID

Education

Dr. Fatemeh Shirani completed her academic journey with distinction in Nutritional Sciences, earning her foundational and advanced degrees from leading Iranian institutions. She further enriched her expertise through doctoral-level research at Ahvaz Jundishapur University of Medical Sciences, where she focused on the intricate links between nutrition and chronic diseases. Her academic training was complemented by international research at Victoria University in Melbourne, Australia, where she deepened her skills in nutritional biomedicine and clinical research methodologies. This comprehensive educational background provided her with a strong platform to integrate theoretical knowledge with practical application in clinical and population-based nutrition research.

Experience

Dr. Fatemeh Shirani has accumulated extensive experience across research, teaching, and scientific service. She has contributed to large-scale community-based projects, such as national nutrition surveys and heart health programs, aimed at improving public health outcomes through evidence-based interventions. As a dedicated educator, she has taught undergraduate and graduate students, instilling in them the principles of basic nutrition, clinical dietetics, and community health. Her expertise extends to laboratory techniques such as PCR and cell culture, which she has applied to translational nutrition studies. Beyond academia, she has actively participated as a reviewer for prestigious international journals, shaping the quality of published science in her field. Her professional journey reflects a balance of teaching, research, community service, and scientific leadership.

Research Interests

Dr. Fatemeh Shirani’s research interests lie at the intersection of nutrition, epidemiology, and chronic disease management. She is deeply invested in exploring obesity and weight-loss strategies, nutritional interventions for diabetes and metabolic disorders, and the role of diet in preventing cardiovascular disease. Her work also investigates the emerging field of “infectobesity,” examining the connections between viral infections and obesity. By employing systematic reviews, meta-analyses, and clinical trials, she provides high-quality evidence that informs dietary recommendations and policy guidelines. Her studies not only address the biological mechanisms of nutrition-related diseases but also emphasize the translation of findings into practical interventions for populations at risk.

Awards

Dr. Fatemeh Shirani has been widely recognized for her contributions to nutritional sciences, particularly her ability to merge clinical expertise with public health perspectives. Her nomination for the Women Researcher Award reflects her outstanding achievements in advancing women’s representation in scientific leadership and her sustained impact on global nutrition research. She has consistently demonstrated excellence through her publications, conference presentations, and active participation in national and international nutrition societies. This recognition highlights not only her scientific accomplishments but also her commitment to mentoring young researchers and fostering collaborative networks across borders.

Publication

Dr. Fatemeh Shirani has produced a rich body of work that has been widely cited in international literature. Selected publications include:

Title: Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases incidence: a systematic review and meta-analysis
Journal: Nutrition
Published on: 2013
Citation: 482

Title: The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta‐analysis of randomized controlled trials
Journal: Obesity Reviews
Published on: 2016
Citation: 308

Title: Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials
Journal: Nutrition
Published on: 2013
Citation: 288

Title: The role of magnesium in sleep health: a systematic review of available literature
Journal: Biological Trace Element Research
Published on: 2023
Citation: 104

Title: Is phase angle a valuable prognostic tool in cancer patients’ survival? A systematic review and meta-analysis of available literature
Journal: Clinical Nutrition
Published on: 2021
Citation: 98

Title: Vinegar consumption can attenuate postprandial glucose and insulin responses; a systematic review and meta-analysis of clinical trials
Journal: Diabetes Research and Clinical Practice
Published on: 2017
Citation: 95

Title: Effects of concentrated pomegranate juice on subclinical inflammation and cardiometabolic risk factors for type 2 diabetes: A quasi-experimental study
Journal: International Journal of Endocrinology and Metabolism
Published on: 2016
Citation: 55

Conclusion

In conclusion, Dr. Fatemeh Shirani stands as a leading figure in nutritional sciences whose contributions have advanced both research and practice in the prevention and management of chronic diseases. Her ability to translate complex scientific findings into practical dietary strategies has had a lasting impact on public health. With her strong publication record, global collaborations, and dedication to mentorship, she exemplifies the qualities of an outstanding woman researcher. Her nomination for the Women Researcher Award reflects not only her academic excellence but also her leadership, vision, and commitment to improving health outcomes through nutrition science.